Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac κ-opioid receptor stimulation

Por Bolte, Craig, Newman, Gilbert, Schultz, Jo El J.
Publicado em 2009

Kappa and delta opioid receptor signaling is augmented in the failing heart

Por Bolte, Craig, Newman, Gilbert, Schultz, Jo El J.
Publicado em 2009

The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling

Por Liao, Siyun, Porter, Darius, Scott, Alana, Newman, Gilbert, Doetschman, Thomas, Schultz, Jo El J.
Publicado em 2006

The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury

Por Liao, Siyun, Bodmer, Janet R., Azhar, Mohamad, Newman, Gilbert, Coffin, J. Douglas, Doetschman, Thomas, Schultz, Jo El J.
Publicado em 2010

Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction

Por Manning, Janet R., Perkins, Sarah O., Sinclair, Elizabeth A., Gao, Xiaoqian, Zhang, Yu, Newman, Gilbert, Pyle, W. Glen, Schultz, Jo El J.
Publicado em 2013

Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy

Por Schulz, Emily M., Correll, Richard N., Sheikh, Hajer N., Lofrano-Alves, Marco S., Engel, Patti L., Newman, Gilbert, Schultz, Jo El J., Molkentin, Jeffery D., Wolska, Beata M., Solaro, R. John, Wieczorek, David F.
Publicado em 2012